Stockholm - Delayed Quote SEK

Xbrane Biopharma AB (publ) (XBRANE.ST)

0.2246
+0.0092
+(4.27%)
At close: May 30 at 5:29:43 PM GMT+2
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
842,429
653,508
690,515
688,427
Total Liabilities Net Minority Interest
633,890
482,173
265,627
256,686
Total Equity Gross Minority Interest
208,539
171,335
424,888
431,741
Total Capitalization
274,910
284,232
424,888
431,741
Common Stock Equity
208,539
171,335
424,888
431,741
Capital Lease Obligations
42,847
56,082
38,220
44,381
Net Tangible Assets
40,852
71,665
322,893
382,069
Working Capital
67,958
135,136
276,955
341,341
Invested Capital
357,410
346,732
424,888
431,741
Tangible Book Value
40,852
71,665
322,893
382,069
Total Debt
191,718
231,479
38,220
44,381
Net Debt
24,541
109,995
--
--
Share Issued
1,529,483.3970
262,955.0660
242,628.5960
220,875.2010
Ordinary Shares Number
1,529,483.3970
262,955.0660
242,628.5960
220,875.2010
12/31/2021 - 2/3/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers